Filana Therapeutics, Inc.
- Last sale
- Nov 12, 2026 · -8.83%
- Market cap
- $22.10M
- 50.27M shares
- Filings
- 1,013
Q4 2013+277.6% FY13 yoy
Q3 2026N/M FY25 yoy
Q3 2026N/M FY25 yoy
Q3 2026derivedN/M FY25 yoy
FY 2025N/M FY25 yoy
Q3 2026−25.7% FY25 yoy
- $22.10M
- —
- —
- 0.4×
- -148.58%
- —
FY2025 figures · derived
Price
Nov 12, 2026 · IEX last sale
IEX last saleClose of recordAs traded
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Financials
Research And Development
| Period | Ended | Value | Kind | Source trail |
|---|---|---|---|---|
| FY 2025 | 2025-12-31 | $26,590,000 | reported | |
| FY 2024 | 2024-12-31 | $69,637,000 | reported | |
| FY 2023 | 2023-12-31 | $89,423,000 | reported | |
| FY 2022 | 2022-12-31 | $68,032,000 | reported | |
| FY 2021 | 2021-12-31 | $24,813,000 | reported | |
| FY 2018 | 2018-12-31 | $2,969,000 | reported | |
| FY 2017 | 2017-12-31 | $7,615,000 | reported | |
| FY 2016 | 2016-12-31 | $9,176,000 | reported | |
| FY 2015 | 2015-12-31 | $9,100,000 | reported | |
| FY 2014 | 2014-12-31 | $7,306,000 | reported | |
| FY 2013 | 2013-12-31 | $4,917,000 | reported | |
| FY 2012 | 2012-12-31 | $7,605,000 | reported |
Pharmaceutical preparations
Filana Therapeutics, Inc. is the 376th largest of the 552 covered companies the SEC files under this code, by market cap. SIC 2834
CompanyRevenueGrowthNet marginMarket cap
RNAZTranscode Therapeutics, Inc.———$24.2MCPHIChina Pharma Holdings, Inc.$4.1M8.5%76.9%$24.1MMIRAMira Pharmaceuticals, Inc.———$23.3MBETRFBetterLife Pharma Inc.Fiscal 2018 figures———$22.8MSHPHShuttle Pharmaceuticals Holdings, Inc.———$22.7M
FLNAFilana Therapeutics, Inc. (this company)———$22.1M
IGCIGC Pharma, Inc.Fiscal 2025 figures———$21.9MCELUCelularity Inc$26.6M51.0%345.4%$21.8MTXMDTherapeuticsMD, Inc.$3.0M71.6%18.8%$20.9MPeers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in market cap first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.
Filana Therapeutics, Inc. · CIK 1069530 · Engraved from SEC EDGAR